Clinical Decision Support Tool

for timely diagnosis of dementia

Brendan Crossey

Enhancing the World of Dementia Diagnosis
+44(0) 7557 909 998
  • This field is for validation purposes and should be left unchanged.

By submitting my data I agree to be contacted

Clinical Decision Support Tool

for timely diagnosis of dementia

1,000,000 people will have Dementia in the UK by 2025

The cost of dementia will double from £34.7bn to £94bn by 2040.

GPs do not feel adequately trained in diagnosing dementia

It is crucial to diagnose Dementia in early stages to promote optimal management

  • The Problem

50m people worldwide
growing to 152m in 2050

Dementia is one of the major causes of disability and dependency among older people worldwide. There is no treatment currently available to cure dementia or to alter its progressive course. However, much can be offered to support and improve the lives of people with dementia and their carers and families and it is crucial to diagnose Dementia in early stages to promote optimal management.

We can help
  • The Problem

50m people worldwide
growing to 152m in 2050

Dementia is one of the major causes of disability and dependency among older people worldwide. There is no treatment currently available to cure dementia or to alter its progressive course. However, much can be offered to support and improve the lives of people with dementia and their carers and families and it is crucial to diagnose Dementia in early stages to promote optimal management.

We can help

1,000,000 people will have Dementia in the UK by 2025

The cost of dementia will double from £26bn to £55bn by 2040.

GPs are not adequately trained in diagnosing dementia

It is crucial to diagnose Dementia in early stages to promote optimal management

  • The Potential Savings

$7tn of savings in USA
if 88% are diagnosed early

NHS estimated savings per patient with Dementia with timely diagnosis

A third of people living with dementia do not have a  formal diagnosis

We can help

Alzheimer’s Association calculate $7tn of savings in USA with timely diagnosis

NICE estimate savings from preventing or delaying dementia by one year at £20K per patient

  • Our Solution

Digital platform using Machine Learning Algorithm that puts a virtual dementia specialist in every GP practice.

Allows for standardisation of assessments

Enhances accuracy of diagnosing dementia

Increases productivity of dementia specialists

Time and cost optimization

We created digital platform that works like there is a virtual dementia specialist present 24\7 in every GP practice.

This offers a lot of benefits:

  • better accuracy of diagnosing dementia as each GP can access full database with our platform.
    Other positive outcome is increased productivity of dementia specialists – they can diagnose faster and with more confidence.
    Also, time consuming data collection can now be done on digital app by practice nurses in primary care, thus freeing time for doctors and optimizing costs for medical institution.
  • First Dementia Data Repository of its type in the world
  • Service delivers 82% accuracy, 84% Sensitivity and Specificity
  • Sensitivity and specificity are statistical measures of the performance of a binary classification test, also known in statistics as a classification function, that are widely used in medicine:
    • Sensitivity (also called the true positive rate, the epidemiological/clinical sensitivity, the recall, or probability of detection in some fields) measures the proportion of actual positives that are correctly identified as such (e.g., the percentage of sick people who are correctly identified as having the condition). It is often mistakenly confused with the detection limit, while the detection limit is calculated from the analytical sensitivity, not from the epidemiological sensitivity.
    • Specificity (also called the true negative rate) measures the proportion of actual negatives that are correctly identified as such (e.g., the percentage of healthy people who are correctly identified as not having the condition).

Note that the terms “positive” and “negative” do not refer to the value of the condition of interest, but to its presence or absence; the condition itself could be a disease, so that “positive” might mean “diseased”, while “negative” might mean “healthy”.

We test this by using real patient diagnosis data that has not previously used to test the service – At the start of the process we take all the patient data and use 90% for the service to learn from and we keep back 10% to test the system.

The Current Care Pathway

GPs do not feel confident in using current diagnostic tools

According to NICE, 94% patients are referred onwards to Specialists

Person with Suspected dementia

Initial mini assessment with GP

99% Patients Referred

Full Assessment with Specialist

Dementia Subtypes Diagnosis

Dementia Care Management

GPs do not feel confident in using current diagnostic tools

According to NICE, 94% patients are referred onwards to Specialists

The New Care Pathway

Helping to deliver a new standardised assessment

Person with Suspected dementia

Nurse collects data. Predicted diagnosis is sent to GP

GP makes Timely & Informed Diagnosis

Up to 80% less Patients Referred *

Specialists use data collected to diagnose dementia type

Dementia Care Management

Helping to deliver a new standardised assessment

  • Market Opportunity

Estimated costs of misdiagnosis are
£3bn in the UK

The OECD report on “Wasteful Spending in Health” (2017) presented alarming data on inappropriate care and wasted resources with estimations ranging from a conservative 10% up to 34% of expenditures.

The UK National Institute for Health and Care Excellence (NICE) costing statement of October 2015 estimated the savings from preventing or delaying dementia for one year from the timely diagnosis of dementia would be £ 5,285 for the NHS per person with dementia, £5,537 for Local Authorities and £ 4,228 for Central Government.

No longer is the healthcare industry focused on simply a fee for a service, but on delivering outcomes. Healthcare service providers are now being paid by helping people stay healthy and reducing the need for more expensive treatments in the future.

We believe that this proactive approach benefits commercial companies like Nightingale Analytics, healthcare providers like the NHS and service users.

We can help

Need additional information or have a question or comment?

Please feel free to leave your details and we will get back to you as soon as possible.

Brendan Crossey

Enhancing the World of Dementia Diagnosis
+44(0) 7557 909 998
  • This field is for validation purposes and should be left unchanged.

By submitting my data I agree to be contacted